Jean-Christophe Ianotto

21PUBLICATIONS
102CO-AUTHORS
Medical infection agents (incl. prions)Paediatrics not elsewhere classifiedRespiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 04, 2026
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.

|Aug 03, 2026
Use of Ruxolitinib in Pediatric Polycythemia Vera: Expanding Indications Beyond Adult Paradigms? A Case Report.

|May 13, 2026
Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.

|Dec 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Alexandre Guy, Olivier Mansier, Matisse Decilap

|Dec 15, 2025
Ruxolitinib and Hydroxycarbamide Are the Most Efficient Drugs to Reduce Aquagenic Pruritus Intensity in a Real-Word Cohort of Patients With Myeloproliferative Neoplasms.

Christelle Le Gall-Ianotto, Lanig Civi, Brigitte Pan-Petesch

|Oct 17, 2025
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro

Pageof 4

Frequent Collaborators

7 joint publications

Eric Lippert

7 joint publications

Damien Luque Paz

5 joint publications

Jérémie Riou

5 joint publications

Léa Sureau